NASDAQ: HOOKHookipa Pharma Inc Stock Ownership - Who owns Hookipa Pharma?
Insider buying vs selling
Have Hookipa Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Reinhard Kandera | Chief Financial Officer | 2023-08-21 | 7,000 | $0.73 | $5.08kBuy |
| Reinhard Kandera | Chief Financial Officer | 2023-08-16 | 8,000 | $0.71 | $5.71kBuy |
| Jorn Aldag | Chief Executive Officer | 2023-07-11 | 5,000 | $0.83 | $4.14kBuy |
| Jorn Aldag | Chief Executive Officer | 2023-07-07 | 5,000 | $0.81 | $4.05kBuy |
| Jorn Aldag | Chief Executive Officer | 2023-07-05 | 5,000 | $0.89 | $4.45kBuy |
| Jorn Aldag | Chief Executive Officer | 2023-07-03 | 5,000 | $0.89 | $4.46kBuy |
| Reinhard Kandera | Chief Financial Officer | 2023-06-30 | 12,000 | $0.88 | $10.56kBuy |
HOOK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HOOK insiders and whales buy or sell their stock.
HOOK Shareholders
What type of owners hold Hookipa Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gilead Sciences Inc | 18.96% | 18,759,465 | $14.35M | Insider |
| Baker Bros Advisors LP | 8.21% | 8,128,151 | $6.22M | Institution |
| Artal Group Sa | 5.73% | 5,666,410 | $4.33M | Institution |
| Knoll Capital Management LLC | 5.58% | 5,517,385 | $4.22M | Institution |
| Ecor1 Capital LLC | 4.64% | 4,595,024 | $3.52M | Institution |
| Fmr LLC | 3.39% | 3,358,383 | $2.57M | Institution |
| Sofinnova Capital Vi Fcpr | 3.21% | 3,177,574 | $2.43M | Insider |
| Forbion Capital Fund Ii Cooperatief Ua | 2.52% | 2,494,173 | $1.91M | Insider |
| Vanguard Group Inc | 2.14% | 2,114,802 | $1.62M | Institution |
| Morgan Stanley | 1.20% | 1,184,072 | $905.82k | Institution |
HOOK vs Biotech Stocks
Hookipa Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.